Discover the groundbreaking findings from a study on bispecific T-cell engagers conducted by The Jackson Laboratory. This case study delves into the tools available for assessing cytokine release and tumour growth inhibition. Explore the implications of donor-specific responses and how this knowledge can optimise the development of immunomodulatory therapeutics.
What you will learn:
Don't miss this opportunity to gain valuable insights into the future of bispecifics and the advancement of immuno-oncology therapeutics.
Brought to you by